Latest
Thilo Beck at WEF Roundtable - A Roadmap to Sustainable Health and Better Well-being in the Workforce and Society

Goals House Roundtable, World Economic Forum, Davos – Thilo Beck

A Roadmap to Sustainable Health and Better Well-being in the Workforce and Society: Elaborating on Key Points.   We are living through a historical period defined by uncertainty, which is having a profound impact on our mental health. Research shows that – on average, 15% of working-age adults live with a mental health condition globally,…

Read more

Affluent Neglect

Society expresses great concern for poor, underserved children and the increased likelihood they may lack access to health care and education, or that they may turn to drugs or crime in adulthood. Less attention is paid to children of affluent parents who have their own set of problems. Emotional neglect often goes unnoticed or unreported, which may…

Read more

What is Dialectical Behavior Therapy?

Dialectical behavior therapy (DBT), developed by Marsha Linehan, Ph. in the 1980s, is a type of talk therapy originally designed for high-risk, suicidal people diagnosed with borderline personality disorder. Today, DBT is used to treat people struggling with a range of complex and intense emotions, including substance abuse and addiction, PTSD, bipolar disorder, eating disorders,…

Read more

The Pandemic-Push: Why are so Many People Suddenly Buying Prescription Drugs Online?

Prescription-med sales skyrocket due to the pandemic, but when does use become abuse? Paracelsus Recovery’s experts weigh in. More and more people are illegally purchasing prescription medication such as anxiety or sleeping pills online as the pandemic takes its toll on our wellbeing. The pandemic has left a mental health crisis in its wake. Rates…

Read more
prev
/
next

Psychedelic Treatment: Research and Content

Find all the psychedelic treatment-related content, research and events Paracelsus Recovery is involved with here.

One Client at a Time

Unparalleled staff to patient ratio of 15:1

resurgence of interest in the therapeutic use

Over the past few decades, there has been a resurgence of interest in the therapeutic use of psychedelics. Researchers are uncovering promising results in treating various conditions, from depression and anxiety to addiction and PTSD.

Psychedelic substances like psilocybin, LSD, and MDMA have long been associated with counterculture and illicit drug use. However, recent studies have demonstrated their potential as powerful tools for healing and personal growth. Through carefully guided sessions with trained therapists, individuals have reported transformative experiences that have helped them break free from negative thought patterns, overcome trauma, and improve their overall quality of life.

 

Paracelsus Recovery is one of the few high-end European-based treatment centres supporting the psychedelic revolution. We are legally permitted to provide ketamine-assisted psychotherapy at our centre in Zurich, Switzerland. However, we hope to offer other psychedelic treatment options as soon as legalisation permits. In the meantime, we are active and involved in various ways:

I. Public Speaking Events

FT Weekend: All you wanted to know about psychedelics...

... but were afraid to ask.

Once demonised, ketamine, LSD and psilocybin are now used to treat everything from PTSD to depression. Are they working? Moderated by Beatrice Hodgkin, deputy editor, HTSI, the conference will include insights from our founder, Jan Gerber, along with Neil Markey, Beckley Retreats and Matthew W. Johnson, professor of psychiatry and behavioural sciences, Johns Hopkins. 

 

 

FTWeekend

The REACH at The Kennedy Centre, Online & On Demand

Saturday, May 20, 12.00 PM – 12.45 PM EDT.

Jan Gerber is the founder and CEO of Swiss Clinics Group and Paracelsus Recovery, a specialist clinic providing state-of-the-art mental health and addiction treatment to high-profile international clientele in Zurich and London. He holds an MSc in Finance from the London School of Economics. After a few years in the consulting industry, he founded several companies in the healthcare sector, including several clinics. He also holds several board seats. Jan is a frequent speaker on mental health awareness, particularly on the intersection of mental health and wealth, as well as state-of-the-art, experimental and complementary approaches to mental health treatments.

Jan A. Gerber, founder and CEO of Swiss Clinics Group and Paracelsus Recovery

Financial Times Weekend Life Streaming

As soon as the conference starts, you will find the lifestreaming video here.

 

 

Latest Articles

Ayahuasca Treatment: Can a Psychedelic Plant Have Therapeutic Benefits?

Will Psychedelic Drugs Revolutionise Psychiatric Treatment?

Which Drugs are Leading the Psychedelic Revolution?

Treatment Programmes

Ketamine-Assisted Therapy for Treatment-Resistant Depression

Ketamine-Assisted Therapy at Paracelsus Recovery